GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

Jan 15 (Reuters) - GlaxoSmithKline (GSK.L) on Saturday said it had rejected a 50-billion-pound offer from Unilever (ULVR.L) for its consumer goods arm, saying it "fundamentally undervalued" the ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

GlaxoSmithKline GSK announced that it had received three unsolicited, conditional and non-binding proposals from British multinational consumer goods company, Unilever UL for its Consumer business ...

GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm. GSK was named one of the 100 Best Companies for ...

Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report To read this article on Zacks.com click here.

NurPhoto via Getty Images On April 27, 2022, GlaxoSmithKline GSK -2.9% plc (NYSE: GSK, $45.44, Market Capitalization: $115.5 billion) reported 1Q22 results.

GlaxoSmithKline PLC GSK -3.16% has agreed to buy Sierra Oncology Inc. for $1.9 billion, in a deal that will boost the British pharmaceutical giant’s cancer drug pipeline. The deal centers on a ...